TheEdgeResearch
Home / Stocks / BCBCF

The BC Bud Corporation (BCBCF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.04 ▼ -3.31%
Market Cap
$6.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.98
52-Wk Range
0.003-0.1166
CEO
Brayden Robert Sutton
Country
CA
Currency
USD

The BC Bud Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.04, down 3.31% on the session, giving a market capitalisation of $6.0M. On trailing twelve-month figures it carries a trailing P/E of -1.96, a net margin of -1990.9%. Its beta of 1.98 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-1.96
Price / Sales
139.51
Price / Book
395.93
EV / EBITDA
-7.36
Gross margin
96.8%
Operating margin
-1990.0%
Net margin
-1990.9%
Return on equity
—
Debt / equity
37.83
Current ratio
0.96
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2022-04-29
Headquarters
Vancouver, BC, CA
About The BC Bud Corporation

Digital Commodities Capital Corp. operates as an investment entity focused on deploying capital across the digital asset landscape. Its diverse portfolio includes digital currencies, tangible commodities such as gold and silver (classified as non-fiat assets), and equity stakes in both privately held and publicly traded organizations, often acquired through private placements. Established in 2000 and headquartered in Vancouver, Canada, the company was previously known as The BC Bud Corporation before officially changing its name to Digital Commodities Capital Corp. in March 2025.

Comparable companies

The BC Bud Corporation is most often compared with the following Healthcare names:

ACRDFACRHFCHNCCLSHDOCRFGHSIIVITFNDVAFSQIDFVVCIF
More research on BCBCF
BCBCF technical analysis BCBCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →